“The present situation has exposed some structural weaknesses in the EU’s medicines source chain and a substantial dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She recommended that supply chain challenges be resolved within an EU pharmaceutical system envisioned to generally be released by the end in… Read More